APO Research
Talk to an analyst

APO RESEARCH · REPORT

Drug-coated Balloon (DCB)

A drug-coated balloon (DCB) is an angioplasty balloon catheter in which an antiproliferative drug is coated onto the balloon surface and delivered to the vessel wall during transient balloon inflation, providing a localized therapeutic effect while leaving no permanent implant behind. The coating is engineered to remain stable on the balloon during tracking and deployment, then rapidly transfer an effective dose into the arterial tissue upon inflation, with the drug retained in the vessel wall to suppress neointimal hyperplasia and reduce restenosis after percutaneous transluminal angioplasty. In clinical use, DCB technology is applied across coronary and peripheral interventions, including femoropopliteal and below-the-knee vessels and selected dialysis-access lesions, and its performance is defined by the balance between deliverability, tissue drug transfer efficiency, and the control of downstream loss of coating material during the procedure.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

A drug-coated balloon (DCB) is an angioplasty balloon catheter in which an antiproliferative drug is coated onto the balloon surface and delivered to the vessel wall during transient balloon inflation, providing a localized therapeutic effect while leaving no permanent implant behind. The coating is engineered to remain stable on the balloon during tracking and deployment, then rapidly transfer an effective dose into the arterial tissue upon inflation, with the drug retained in the vessel wall to suppress neointimal hyperplasia and reduce restenosis after percutaneous transluminal angioplasty. In clinical use, DCB technology is applied across coronary and peripheral interventions, including femoropopliteal and below-the-knee vessels and selected dialysis-access lesions, and its performance is defined by the balance between deliverability, tissue drug transfer efficiency, and the control of downstream loss of coating material during the procedure.

Selected research

Market Structure

Global Drug-coated Balloon (DCB) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

3 August 2026197 pages

Choose your research edition.

Industry ResearchDrug-coated Balloon (DCB) Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Drug-coated Balloon (DCB) Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Drug-coated Balloon (DCB) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drug-coated Balloon (DCB) Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Drug-coated Balloon (DCB) Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

A drug-coated balloon (DCB) is an angioplasty balloon catheter in which an antiproliferative drug is coated onto the balloon surface and delivered to the vessel wall during transient balloon inflation, providing a localized therapeutic effect while leaving no permanent implant behind. The coating is engineered to remain stable on the balloon during tracking and deployment, then rapidly transfer an effective dose into the arterial tissue upon inflation, with the drug retained in the vessel wall to suppress neointimal hyperplasia and reduce restenosis after percutaneous transluminal angioplasty. In clinical use, DCB technology is applied across coronary and peripheral interventions, including femoropopliteal and below-the-knee vessels and selected dialysis-access lesions, and its performance is defined by the balance between deliverability, tissue drug transfer efficiency, and the control of downstream loss of coating material during the procedure.

The global Drug-coated Balloon (DCB) market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Drug-coated Balloon (DCB) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Europe market for Drug-coated Balloon (DCB) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Asia Pacific market for Drug-coated Balloon (DCB) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Drug-coated Balloon (DCB) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Drug-coated Balloon (DCB) include Medtronic, Boston Scientific, Becton Dickinson, Biotronik, B. Braun, Philips, Abbott, Eurocor and Yinyi Biotech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Drug-coated Balloon (DCB) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Drug-coated Balloon (DCB) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Drug-coated Balloon (DCB) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Drug-coated Balloon (DCB) market size, projected growth trends, production technologies, key applications, and end-use industries.

Drug-coated Balloon (DCB) Segment by Company

Medtronic

Boston Scientific

Becton Dickinson

Biotronik

B. Braun

Philips

Abbott

Eurocor

Yinyi Biotech

Lepu Medical

Grand Pharma

Acotec Scientific

Shenqi Medical

MicroPort

Zylox-Tonbridge Medical

Zhejiang Barty Medical

Drug-coated Balloon (DCB) Segment by Type

Coronary DCB

Peripheral DCB (FP)

Peripheral DCB (BTK)

Drug-coated Balloon (DCB) Segment by Application

Dialysis Access (AVF/AVG)

Femoropopliteal (FP)

Below-the-Knee (BTK)

Drug-coated Balloon (DCB) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug-coated Balloon (DCB) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drug-coated Balloon (DCB) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug-coated Balloon (DCB).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Drug-coated Balloon (DCB) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Drug-coated Balloon (DCB) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Drug-coated Balloon (DCB) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Drug-coated Balloon (DCB) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Drug-coated Balloon (DCB) Industry Trends Table 2. Drug-coated Balloon (DCB) Industry Drivers Table 3. Drug-coated Balloon (DCB) Industry Opportunities and Challenges Table 4. Drug-coated Balloon (DCB) Industry Restraints Table 5. Global Drug-coated Balloon (DCB) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Drug-coated Balloon (DCB) Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Drug-coated Balloon (DCB) Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Drug-coated Balloon (DCB) Sales Market Share by Manufacturers Table 9. Global Drug-coated Balloon (DCB) Average Sales Price (USD/unit) of Manufacturers (2021-2026) Table 10. Global Drug-coated Balloon (DCB) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Drug-coated Balloon (DCB) Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Drug-coated Balloon (DCB) Manufacturers, Product Type & Application Table 13. Global Drug-coated Balloon (DCB) Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Drug-coated Balloon (DCB) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Coronary DCB Table 17. Major Manufacturers of Peripheral DCB (FP) Table 18. Major Manufacturers of Peripheral DCB (BTK) Table 19. Global Drug-coated Balloon (DCB) Sales by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Drug-coated Balloon (DCB) Sales by Type (2021-2026) & (k units) Table 21. Global Drug-coated Balloon (DCB) Sales by Type (2027-2032) & (k units) Table 22. Global Drug-coated Balloon (DCB) Sales Market Share by Type (2021-2026) Table 23. Global Drug-coated Balloon (DCB) Sales Market Share by Type (2027-2032) Table 24. Global Drug-coated Balloon (DCB) Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 25. Global Drug-coated Balloon (DCB) Revenue by Type (2021-2026) & (k units) Table 26. Global Drug-coated Balloon (DCB) Revenue by Type (2027-2032) & (k units) Table 27. Global Drug-coated Balloon (DCB) Revenue Market Share by Type (2021-2026) Table 28. Global Drug-coated Balloon (DCB) Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Dialysis Access (AVF/AVG) Table 30. Major Manufacturers of Femoropopliteal (FP) Table 31. Major Manufacturers of Below-the-Knee (BTK) Table 32. Global Drug-coated Balloon (DCB) Sales by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Drug-coated Balloon (DCB) Sales by Application (2021-2026) & (k units) Table 34. Global Drug-coated Balloon (DCB) Sales by Application (2027-2032) & (k units) Table 35. Global Drug-coated Balloon (DCB) Sales Market Share by Application (2021-2026) Table 36. Global Drug-coated Balloon (DCB) Sales Market Share by Application (2027-2032) Table 37. Global Drug-coated Balloon (DCB) Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 38. Global Drug-coated Balloon (DCB) Revenue by Application (2021-2026) & (k units) Table 39. Global Drug-coated Balloon (DCB) Revenue by Application (2027-2032) & (k units) Table 40. Global Drug-coated Balloon (DCB) Revenue Market Share by Application (2021-2026) Table 41. Global Drug-coated Balloon (DCB) Revenue Market Share by Application (2027-2032) Table 42. Global Drug-coated Balloon (DCB) Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Drug-coated Balloon (DCB) Sales by Region (2021-2026) & (k units) Table 44. Global Drug-coated Balloon (DCB) Sales Market Share by Region (2021-2026) Table 45. Global Drug-coated Balloon (DCB) Sales Forecasted by Region (2027-2032) & (k units) Table 46. Global Drug-coated Balloon (DCB) Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Drug-coated Balloon (DCB) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 48. North America Drug-coated Balloon (DCB) Sales by Country (2021-2026) & (k units) Table 49. North America Drug-coated Balloon (DCB) Sales by Country (2027-2032) & (k units) Table 50. Europe Drug-coated Balloon (DCB) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 51. Europe Drug-coated Balloon (DCB) Sales by Country (2021-2026) & (k units) Table 52. Europe Drug-coated Balloon (DCB) Sales by Country (2027-2032) & (k units) Table 53. Asia Pacific Drug-coated Balloon (DCB) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Asia Pacific Drug-coated Balloon (DCB) Sales by Country (2021-2026) & (k units) Table 55. Asia Pacific Drug-coated Balloon (DCB) Sales by Country (2027-2032) & (k units) Table 56. South America, Middle East and Africa Drug-coated Balloon (DCB) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 57. South America, Middle East and Africa Drug-coated Balloon (DCB) Sales by Country (2021-2026) & (k units) Table 58. South America, Middle East and Africa Drug-coated Balloon (DCB) Sales by Country (2027-2032) & (k units) Table 59. Global Drug-coated Balloon (DCB) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Drug-coated Balloon (DCB) Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Drug-coated Balloon (DCB) Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Drug-coated Balloon (DCB) Revenue Market Share by Region (2021-2026) Table 63. Global Drug-coated Balloon (DCB) Revenue Market Share by Region (2027-2032) Table 64. Medtronic Company Information Table 65. Medtronic Business Overview Table 66. Medtronic Drug-coated Balloon (DCB) Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Medtronic Drug-coated Balloon (DCB) Product Portfolio Table 68. Medtronic Recent Development Table 69. Boston Scientific Company Information Table 70. Boston Scientific Business Overview Table 71. Boston Scientific Drug-coated Balloon (DCB) Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Boston Scientific Drug-coated Balloon (DCB) Product Portfolio Table 73. Boston Scientific Recent Development Table 74. Becton Dickinson Company Information Table 75. Becton Dickinson Business Overview Table 76. Becton Dickinson Drug-coated Balloon (DCB) Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Becton Dickinson Drug-coated Balloon (DCB) Product Portfolio Table 78. Becton Dickinson Recent Development Table 79. Biotronik Company Information Table 80. Biotronik Business Overview Table 81. Biotronik Drug-coated Balloon (DCB) Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Biotronik Drug-coated Balloon (DCB) Product Portfolio Table 83. Biotronik Recent Development Table 84. B. Braun Company Information Table 85. B. Braun Business Overview Table 86. B. Braun Drug-coated Balloon (DCB) Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. B. Braun Drug-coated Balloon (DCB) Product Portfolio Table 88. B. Braun Recent Development Table 89. Philips Company Information Table 90. Philips Business Overview Table 91. Philips Drug-coated Balloon (DCB) Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Philips Drug-coated Balloon (DCB) Product Portfolio Table 93. Philips Recent Development Table 94. Abbott Company Information Table 95. Abbott Business Overview Table 96. Abbott Drug-coated Balloon (DCB) Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Abbott Drug-coated Balloon (DCB) Product Portfolio Table 98. Abbott Recent Development Table 99. Eurocor Company Information Table 100. Eurocor Business Overview Table 101. Eurocor Drug-coated Balloon (DCB) Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Eurocor Drug-coated Balloon (DCB) Product Portfolio Table 103. Eurocor Recent Development Table 104. Yinyi Biotech Company Information Table 105. Yinyi Biotech Business Overview Table 106. Yinyi Biotech Drug-coated Balloon (DCB) Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Yinyi Biotech Drug-coated Balloon (DCB) Product Portfolio Table 108. Yinyi Biotech Recent Development Table 109. Lepu Medical Company Information Table 110. Lepu Medical Business Overview Table 111. Lepu Medical Drug-coated Balloon (DCB) Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Lepu Medical Drug-coated Balloon (DCB) Product Portfolio Table 113. Lepu Medical Recent Development Table 114. Grand Pharma Company Information Table 115. Grand Pharma Business Overview Table 116. Grand Pharma Drug-coated Balloon (DCB) Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Grand Pharma Drug-coated Balloon (DCB) Product Portfolio Table 118. Grand Pharma Recent Development Table 119. Acotec Scientific Company Information Table 120. Acotec Scientific Business Overview Table 121. Acotec Scientific Drug-coated Balloon (DCB) Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Acotec Scientific Drug-coated Balloon (DCB) Product Portfolio Table 123. Acotec Scientific Recent Development Table 124. Shenqi Medical Company Information Table 125. Shenqi Medical Business Overview Table 126. Shenqi Medical Drug-coated Balloon (DCB) Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Shenqi Medical Drug-coated Balloon (DCB) Product Portfolio Table 128. Shenqi Medical Recent Development Table 129. MicroPort Company Information Table 130. MicroPort Business Overview Table 131. MicroPort Drug-coated Balloon (DCB) Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. MicroPort Drug-coated Balloon (DCB) Product Portfolio Table 133. MicroPort Recent Development Table 134. Zylox-Tonbridge Medical Company Information Table 135. Zylox-Tonbridge Medical Business Overview Table 136. Zylox-Tonbridge Medical Drug-coated Balloon (DCB) Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 137. Zylox-Tonbridge Medical Drug-coated Balloon (DCB) Product Portfolio Table 138. Zylox-Tonbridge Medical Recent Development Table 139. Zhejiang Barty Medical Company Information Table 140. Zhejiang Barty Medical Business Overview Table 141. Zhejiang Barty Medical Drug-coated Balloon (DCB) Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 142. Zhejiang Barty Medical Drug-coated Balloon (DCB) Product Portfolio Table 143. Zhejiang Barty Medical Recent Development Table 144. Key Raw Materials Table 145. Raw Materials Key Suppliers Table 146. Drug-coated Balloon (DCB) Distributors List Table 147. Drug-coated Balloon (DCB) Customers List Table 148. Research Programs/Design for This Report Table 149. Authors List of This Report Table 150. Secondary Sources Table 151. Primary Sources List of Figures Figure 1. Drug-coated Balloon (DCB) Product Image Figure 2. Global Drug-coated Balloon (DCB) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Drug-coated Balloon (DCB) Market Size (2021-2032) & (US$ Million) Figure 4. Global Drug-coated Balloon (DCB) Sales (2021-2032) & (k units) Figure 5. Global Drug-coated Balloon (DCB) Average Price (USD/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Drug-coated Balloon (DCB) Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Coronary DCB Image Figure 9. Peripheral DCB (FP) Image Figure 10. Peripheral DCB (BTK) Image Figure 11. Global Drug-coated Balloon (DCB) Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Drug-coated Balloon (DCB) Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Drug-coated Balloon (DCB) Sales Market Share by Type (2021-2032) Figure 14. Global Drug-coated Balloon (DCB) Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Drug-coated Balloon (DCB) Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Drug-coated Balloon (DCB) Revenue Market Share by Type (2021-2032) Figure 17. Dialysis Access (AVF/AVG) Image Figure 18. Femoropopliteal (FP) Image Figure 19. Below-the-Knee (BTK) Image Figure 20. Global Drug-coated Balloon (DCB) Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Drug-coated Balloon (DCB) Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Drug-coated Balloon (DCB) Sales Market Share by Application (2021-2032) Figure 23. Global Drug-coated Balloon (DCB) Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Drug-coated Balloon (DCB) Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Drug-coated Balloon (DCB) Revenue Market Share by Application (2021-2032) Figure 26. North America Drug-coated Balloon (DCB) Sales and Growth Rate (2021-2032) & (k units) Figure 27. North America Drug-coated Balloon (DCB) Sales Market Share by Country (2021-2032) Figure 28. U.S. Drug-coated Balloon (DCB) Sales and Growth Rate (2021-2032) & (k units) Figure 29. Canada Drug-coated Balloon (DCB) Sales and Growth Rate (2021-2032) & (k units) Figure 30. Mexico Drug-coated Balloon (DCB) Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Drug-coated Balloon (DCB) Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Drug-coated Balloon (DCB) Sales Market Share by Country (2021-2032) Figure 33. Germany Drug-coated Balloon (DCB) Sales and Growth Rate (2021-2032) & (k units) Figure 34. France Drug-coated Balloon (DCB) Sales and Growth Rate (2021-2032) & (k units) Figure 35. U.K. Drug-coated Balloon (DCB) Sales and Growth Rate (2021-2032) & (k units) Figure 36. Italy Drug-coated Balloon (DCB) Sales and Growth Rate (2021-2032) & (k units) Figure 37. Netherlands Drug-coated Balloon (DCB) Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Drug-coated Balloon (DCB) Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Drug-coated Balloon (DCB) Sales Market Share by Country (2021-2032) Figure 40. China Drug-coated Balloon (DCB) Sales and Growth Rate (2021-2032) & (k units) Figure 41. Japan Drug-coated Balloon (DCB) Sales and Growth Rate (2021-2032) & (k units) Figure 42. South Korea Drug-coated Balloon (DCB) Sales and Growth Rate (2021-2032) & (k units) Figure 43. Southeast Asia Drug-coated Balloon (DCB) Sales and Growth Rate (2021-2032) & (k units) Figure 44. India Drug-coated Balloon (DCB) Sales and Growth Rate (2021-2032) & (k units) Figure 45. Australia Drug-coated Balloon (DCB) Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Drug-coated Balloon (DCB) Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Drug-coated Balloon (DCB) Sales Market Share by Country (2021-2032) Figure 48. Brazil Drug-coated Balloon (DCB) Sales and Growth Rate (2021-2032) & (k units) Figure 49. South Africa Drug-coated Balloon (DCB) Sales and Growth Rate (2021-2032) & (k units) Figure 50. Saudi Arabia Drug-coated Balloon (DCB) Sales and Growth Rate (2021-2032) & (k units) Figure 51. Turkey Drug-coated Balloon (DCB) Sales and Growth Rate (2021-2032) & (k units) Figure 52. Argentina Drug-coated Balloon (DCB) Sales and Growth Rate (2021-2032) & (k units) Figure 53. UAE Drug-coated Balloon (DCB) Sales and Growth Rate (2021-2032) & (k units) Figure 54. Egypt Drug-coated Balloon (DCB) Sales and Growth Rate (2021-2032) & (k units) Figure 55. Chile Drug-coated Balloon (DCB) Sales and Growth Rate (2021-2032) & (k units) Figure 56. Global Drug-coated Balloon (DCB) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Drug-coated Balloon (DCB) Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Drug-coated Balloon (DCB) Revenue (2021-2032) & (US$ Million) Figure 59. North America Drug-coated Balloon (DCB) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Drug-coated Balloon (DCB) Revenue (2021-2032) & (US$ Million) Figure 61. Europe Drug-coated Balloon (DCB) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Drug-coated Balloon (DCB) Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Drug-coated Balloon (DCB) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Drug-coated Balloon (DCB) Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Drug-coated Balloon (DCB) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Drug-coated Balloon (DCB) Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Drug-coated Balloon (DCB) Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Coronary DCB
  • Peripheral DCB (FP)
  • Peripheral DCB (BTK)
Applications
  • Dialysis Access (AVF/AVG)
  • Femoropopliteal (FP)
  • Below-the-Knee (BTK)
Companies covered
  • Medtronic
  • Boston Scientific
  • Becton Dickinson
  • Biotronik
  • B. Braun
  • Philips
  • Abbott
  • Eurocor
  • Yinyi Biotech
  • Lepu Medical
  • Grand Pharma
  • Acotec Scientific
  • Shenqi Medical
  • MicroPort
  • Zylox-Tonbridge Medical
  • Zhejiang Barty Medical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Drug-coated Balloon (DCB) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Drug-coated Balloon (DCB) Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Drug-coated Balloon (DCB) Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Drug-coated Balloon (DCB) Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Drug-coated Balloon (DCB) Market Dynamics
  1. 2.1 Drug-coated Balloon (DCB) Industry Trends
  2. 2.2 Drug-coated Balloon (DCB) Industry Drivers
  3. 2.3 Drug-coated Balloon (DCB) Industry Opportunities and Challenges
  4. 2.4 Drug-coated Balloon (DCB) Industry Restraints
3 Drug-coated Balloon (DCB) Market by Manufacturers
  1. 3.1 Global Drug-coated Balloon (DCB) Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Drug-coated Balloon (DCB) Sales by Manufacturers (2021-2026)
  3. 3.3 Global Drug-coated Balloon (DCB) Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Drug-coated Balloon (DCB) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Drug-coated Balloon (DCB) Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Drug-coated Balloon (DCB) Manufacturers, Product Type & Application
  7. 3.7 Global Drug-coated Balloon (DCB) Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Drug-coated Balloon (DCB) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Drug-coated Balloon (DCB) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Drug-coated Balloon (DCB) Tier 1, Tier 2, and Tier 3
4 Drug-coated Balloon (DCB) Market by Type
  1. 4.1 Drug-coated Balloon (DCB) Type Introduction
  2. 4.1.1 Coronary DCB
  3. 4.1.2 Peripheral DCB (FP)
  4. 4.1.3 Peripheral DCB (BTK)
  5. 4.2 Global Drug-coated Balloon (DCB) Sales by Type
  6. 4.2.1 Global Drug-coated Balloon (DCB) Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Drug-coated Balloon (DCB) Sales by Type (2021-2032)
  8. 4.2.3 Global Drug-coated Balloon (DCB) Sales Market Share by Type (2021-2032)
  9. 4.3 Global Drug-coated Balloon (DCB) Revenue by Type
  10. 4.3.1 Global Drug-coated Balloon (DCB) Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Drug-coated Balloon (DCB) Revenue by Type (2021-2032)
  12. 4.3.3 Global Drug-coated Balloon (DCB) Revenue Market Share by Type (2021-2032)
5 Drug-coated Balloon (DCB) Market by Application
  1. 5.1 Drug-coated Balloon (DCB) Application Introduction
  2. 5.1.1 Dialysis Access (AVF/AVG)
  3. 5.1.2 Femoropopliteal (FP)
  4. 5.1.3 Below-the-Knee (BTK)
  5. 5.2 Global Drug-coated Balloon (DCB) Sales by Application
  6. 5.2.1 Global Drug-coated Balloon (DCB) Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Drug-coated Balloon (DCB) Sales by Application (2021-2032)
  8. 5.2.3 Global Drug-coated Balloon (DCB) Sales Market Share by Application (2021-2032)
  9. 5.3 Global Drug-coated Balloon (DCB) Revenue by Application
  10. 5.3.1 Global Drug-coated Balloon (DCB) Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Drug-coated Balloon (DCB) Revenue by Application (2021-2032)
  12. 5.3.3 Global Drug-coated Balloon (DCB) Revenue Market Share by Application (2021-2032)
6 Global Drug-coated Balloon (DCB) Sales by Region
  1. 6.1 Global Drug-coated Balloon (DCB) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Drug-coated Balloon (DCB) Sales by Region (2021-2032)
  3. 6.2.1 Global Drug-coated Balloon (DCB) Sales by Region (2021-2026)
  4. 6.2.2 Global Drug-coated Balloon (DCB) Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Drug-coated Balloon (DCB) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Drug-coated Balloon (DCB) Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Drug-coated Balloon (DCB) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Drug-coated Balloon (DCB) Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Drug-coated Balloon (DCB) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Drug-coated Balloon (DCB) Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Drug-coated Balloon (DCB) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Drug-coated Balloon (DCB) Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Drug-coated Balloon (DCB) Revenue by Region
  1. 7.1 Global Drug-coated Balloon (DCB) Revenue by Region
  2. 7.1.1 Global Drug-coated Balloon (DCB) Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Drug-coated Balloon (DCB) Revenue by Region (2021-2026)
  4. 7.1.3 Global Drug-coated Balloon (DCB) Revenue by Region (2027-2032)
  5. 7.1.4 Global Drug-coated Balloon (DCB) Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Drug-coated Balloon (DCB) Revenue (2021-2032)
  8. 7.2.2 North America Drug-coated Balloon (DCB) Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Drug-coated Balloon (DCB) Revenue (2021-2032)
  11. 7.3.2 Europe Drug-coated Balloon (DCB) Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Drug-coated Balloon (DCB) Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Drug-coated Balloon (DCB) Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Drug-coated Balloon (DCB) Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Drug-coated Balloon (DCB) Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Medtronic
  2. 8.1.1 Medtronic Company Information
  3. 8.1.2 Medtronic Business Overview
  4. 8.1.3 Medtronic Drug-coated Balloon (DCB) Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Medtronic Drug-coated Balloon (DCB) Product Portfolio
  6. 8.1.5 Medtronic Recent Developments
  7. 8.2 Boston Scientific
  8. 8.2.1 Boston Scientific Company Information
  9. 8.2.2 Boston Scientific Business Overview
  10. 8.2.3 Boston Scientific Drug-coated Balloon (DCB) Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Boston Scientific Drug-coated Balloon (DCB) Product Portfolio
  12. 8.2.5 Boston Scientific Recent Developments
  13. 8.3 Becton Dickinson
  14. 8.3.1 Becton Dickinson Company Information
  15. 8.3.2 Becton Dickinson Business Overview
  16. 8.3.3 Becton Dickinson Drug-coated Balloon (DCB) Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Becton Dickinson Drug-coated Balloon (DCB) Product Portfolio
  18. 8.3.5 Becton Dickinson Recent Developments
  19. 8.4 Biotronik
  20. 8.4.1 Biotronik Company Information
  21. 8.4.2 Biotronik Business Overview
  22. 8.4.3 Biotronik Drug-coated Balloon (DCB) Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Biotronik Drug-coated Balloon (DCB) Product Portfolio
  24. 8.4.5 Biotronik Recent Developments
  25. 8.5 B. Braun
  26. 8.5.1 B. Braun Company Information
  27. 8.5.2 B. Braun Business Overview
  28. 8.5.3 B. Braun Drug-coated Balloon (DCB) Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 B. Braun Drug-coated Balloon (DCB) Product Portfolio
  30. 8.5.5 B. Braun Recent Developments
  31. 8.6 Philips
  32. 8.6.1 Philips Company Information
  33. 8.6.2 Philips Business Overview
  34. 8.6.3 Philips Drug-coated Balloon (DCB) Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Philips Drug-coated Balloon (DCB) Product Portfolio
  36. 8.6.5 Philips Recent Developments
  37. 8.7 Abbott
  38. 8.7.1 Abbott Company Information
  39. 8.7.2 Abbott Business Overview
  40. 8.7.3 Abbott Drug-coated Balloon (DCB) Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Abbott Drug-coated Balloon (DCB) Product Portfolio
  42. 8.7.5 Abbott Recent Developments
  43. 8.8 Eurocor
  44. 8.8.1 Eurocor Company Information
  45. 8.8.2 Eurocor Business Overview
  46. 8.8.3 Eurocor Drug-coated Balloon (DCB) Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Eurocor Drug-coated Balloon (DCB) Product Portfolio
  48. 8.8.5 Eurocor Recent Developments
  49. 8.9 Yinyi Biotech
  50. 8.9.1 Yinyi Biotech Company Information
  51. 8.9.2 Yinyi Biotech Business Overview
  52. 8.9.3 Yinyi Biotech Drug-coated Balloon (DCB) Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Yinyi Biotech Drug-coated Balloon (DCB) Product Portfolio
  54. 8.9.5 Yinyi Biotech Recent Developments
  55. 8.10 Lepu Medical
  56. 8.10.1 Lepu Medical Company Information
  57. 8.10.2 Lepu Medical Business Overview
  58. 8.10.3 Lepu Medical Drug-coated Balloon (DCB) Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Lepu Medical Drug-coated Balloon (DCB) Product Portfolio
  60. 8.10.5 Lepu Medical Recent Developments
  61. 8.11 Grand Pharma
  62. 8.11.1 Grand Pharma Company Information
  63. 8.11.2 Grand Pharma Business Overview
  64. 8.11.3 Grand Pharma Drug-coated Balloon (DCB) Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Grand Pharma Drug-coated Balloon (DCB) Product Portfolio
  66. 8.11.5 Grand Pharma Recent Developments
  67. 8.12 Acotec Scientific
  68. 8.12.1 Acotec Scientific Company Information
  69. 8.12.2 Acotec Scientific Business Overview
  70. 8.12.3 Acotec Scientific Drug-coated Balloon (DCB) Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Acotec Scientific Drug-coated Balloon (DCB) Product Portfolio
  72. 8.12.5 Acotec Scientific Recent Developments
  73. 8.13 Shenqi Medical
  74. 8.13.1 Shenqi Medical Company Information
  75. 8.13.2 Shenqi Medical Business Overview
  76. 8.13.3 Shenqi Medical Drug-coated Balloon (DCB) Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Shenqi Medical Drug-coated Balloon (DCB) Product Portfolio
  78. 8.13.5 Shenqi Medical Recent Developments
  79. 8.14 MicroPort
  80. 8.14.1 MicroPort Company Information
  81. 8.14.2 MicroPort Business Overview
  82. 8.14.3 MicroPort Drug-coated Balloon (DCB) Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 MicroPort Drug-coated Balloon (DCB) Product Portfolio
  84. 8.14.5 MicroPort Recent Developments
  85. 8.15 Zylox-Tonbridge Medical
  86. 8.15.1 Zylox-Tonbridge Medical Company Information
  87. 8.15.2 Zylox-Tonbridge Medical Business Overview
  88. 8.15.3 Zylox-Tonbridge Medical Drug-coated Balloon (DCB) Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Zylox-Tonbridge Medical Drug-coated Balloon (DCB) Product Portfolio
  90. 8.15.5 Zylox-Tonbridge Medical Recent Developments
  91. 8.16 Zhejiang Barty Medical
  92. 8.16.1 Zhejiang Barty Medical Company Information
  93. 8.16.2 Zhejiang Barty Medical Business Overview
  94. 8.16.3 Zhejiang Barty Medical Drug-coated Balloon (DCB) Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Zhejiang Barty Medical Drug-coated Balloon (DCB) Product Portfolio
  96. 8.16.5 Zhejiang Barty Medical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Drug-coated Balloon (DCB) Value Chain Analysis
  2. 9.1.1 Drug-coated Balloon (DCB) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Drug-coated Balloon (DCB) Production Mode & Process
  6. 9.2 Drug-coated Balloon (DCB) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Drug-coated Balloon (DCB) Distributors
  9. 9.2.3 Drug-coated Balloon (DCB) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst